<p class="p1">On this episode of the J&J Innovation Podcast, Bill Martin, CSO of Blackthorn Therapeutics, talks about the work they are doing to change the way we think about drug development, specifically as it pertains to treating brain disorders.</p>

On this episode of the J&J Innovation Podcast, Bill Martin, CSO of Blackthorn Therapeutics, talks about the work they are doing to change the way we think about drug development, specifically as it pertains to treating brain disorders.

<p>On this episode of the J&amp;J Innovation Podcast, Bill Martin, CSO of Blackthorn Therapeutics, talks about the work they are doing to change the way we think about drug development, specifically as it pertains to treating brain disorders.</p>

12: Changing the Way We Think About CNS Drug Development

Johnson and  Johnson Innovation is committed to advancing new healthcare solutions through collaboration. Our podcast explores the latest trends in healthcare and the thinkers, organizations, and ideas behind them. Hosted by Caroline Baratz. Produced by Ryan Flinn.

Business

Entrepreneurship

Science

Johnson and Johnson Innovation is committed to advancing new healthcare solutions through collaboration. Our podcast explores the latest trends in healthcare and the thinkers, organizations, and ideas behind them. Hosted by Caroline Baratz. Produced by Ryan Flinn.

Share 12: Changing the Way We Think About CNS Drug Development

Sign up to save your podcasts

12: Changing the Way We Think About CNS Drug Development

12: Changing the Way We Think About CNS Drug Development